rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2001-8-6
|
pubmed:abstractText |
In patients with hypogammaglobulinemia, substitution with immunoglobulin is the treatment of choice to reduce both frequency and severity of bacterial infections. Even with treatment, however, infections still occur in these patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0003-4819
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
135
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
165-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11487483-Adolescent,
pubmed-meshheading:11487483-Adult,
pubmed-meshheading:11487483-Agammaglobulinemia,
pubmed-meshheading:11487483-Aged,
pubmed-meshheading:11487483-Bacterial Infections,
pubmed-meshheading:11487483-Child,
pubmed-meshheading:11487483-Child, Preschool,
pubmed-meshheading:11487483-Cross-Over Studies,
pubmed-meshheading:11487483-Double-Blind Method,
pubmed-meshheading:11487483-Drug Administration Schedule,
pubmed-meshheading:11487483-Female,
pubmed-meshheading:11487483-Humans,
pubmed-meshheading:11487483-Immunoglobulin A,
pubmed-meshheading:11487483-Immunoglobulin G,
pubmed-meshheading:11487483-Immunoglobulin M,
pubmed-meshheading:11487483-Immunoglobulins, Intravenous,
pubmed-meshheading:11487483-Infant,
pubmed-meshheading:11487483-Male,
pubmed-meshheading:11487483-Middle Aged,
pubmed-meshheading:11487483-Recurrence
|
pubmed:year |
2001
|
pubmed:articleTitle |
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.
|
pubmed:affiliation |
CLB, Medical Department, Plesmanlaan 125, 1066 CX Amsterdam, the Netherlands. H_Eijkhout@CLB.nl
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|